ResearcherAsan Medical CenterActive in the last 2 years
Seung Baek Hong
Matched on ORCID iD 0000-0002-1731-0430; OpenAlex author ID A5056334462. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2018: 1 paper · 2019: none · 2020: 3 papers · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 7
- Low prealbumin predicts early recurrence after pancreatic cancer surgery: a retrospective cohort study. Co-author DOI 10.21037/gs-2026-0156↗
- Clinical significance of C-reactive protein-to-prealbumin ratio in predicting early recurrence in resectable pancreatic cancer. Co-author DOI 10.14216/kjco.23003↗
- CT in the prediction of margin-negative resection in pancreatic cancer following neoadjuvant treatment: a systematic review and meta-analysis. Co-author DOI 10.1007/s00330-020-07433-0↗
- Meta-analysis of MRI for the diagnosis of liver metastasis in patients with pancreatic adenocarcinoma. Co-author DOI 10.1002/jmri.26969↗
- Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer. Co-author DOI 10.12998/wjcc.v8.i17.3718↗
- First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapy vs combination chemotherapy. Co-author DOI 10.12998/wjcc.v8.i18.4022↗
- Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria. Co-author DOI 10.1148/radiol.2018180628↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nam Kyung Lee · 5 shared papers, 2020–2026 · strength 0.82
- Paper Low prealbumin predicts early recurrence after pancreatic cancer surgery: a retrospective cohort study. DOI 10.21037/gs-2026-0156↗
- Paper Clinical significance of C-reactive protein-to-prealbumin ratio in predicting early recurrence in resectable pancreatic… DOI 10.14216/kjco.23003↗
- Paper Meta-analysis of MRI for the diagnosis of liver metastasis in patients with pancreatic adenocarcinoma. DOI 10.1002/jmri.26969↗
- Hyung Il Seo · 4 shared papers, 2020–2026 · strength 0.70
- Paper Low prealbumin predicts early recurrence after pancreatic cancer surgery: a retrospective cohort study. DOI 10.21037/gs-2026-0156↗
- Paper Clinical significance of C-reactive protein-to-prealbumin ratio in predicting early recurrence in resectable pancreatic… DOI 10.14216/kjco.23003↗
- Paper Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer. DOI 10.12998/wjcc.v8.i17.3718↗
- Byeong Gwan Noh · 2 shared papers, 2023–2026 · strength 0.45
- Sung Yong Han · 3 shared papers, 2020–2023 · strength 0.43
- Paper Clinical significance of C-reactive protein-to-prealbumin ratio in predicting early recurrence in resectable pancreatic… DOI 10.14216/kjco.23003↗
- Paper Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer. DOI 10.12998/wjcc.v8.i17.3718↗
- Paper First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapy vs combinat… DOI 10.12998/wjcc.v8.i18.4022↗
- Dong Uk Kim · 3 shared papers, 2020–2023 · strength 0.43
- Paper Clinical significance of C-reactive protein-to-prealbumin ratio in predicting early recurrence in resectable pancreatic… DOI 10.14216/kjco.23003↗
- Paper Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer. DOI 10.12998/wjcc.v8.i17.3718↗
- Paper First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapy vs combinat… DOI 10.12998/wjcc.v8.i18.4022↗
- Jin Hee Kim · 3 shared papers, 2018–2021 · strength 0.35
- Paper CT in the prediction of margin-negative resection in pancreatic cancer following neoadjuvant treatment: a systematic re… DOI 10.1007/s00330-020-07433-0↗
- Paper Meta-analysis of MRI for the diagnosis of liver metastasis in patients with pancreatic adenocarcinoma. DOI 10.1002/jmri.26969↗
- Paper Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria. DOI 10.1148/radiol.2018180628↗
- Byung Soo Park · 1 shared paper, 2026 · strength 0.27
- Myeong Hun Oh · 1 shared paper, 2026 · strength 0.27
- Seung Soo Lee · 2 shared papers, 2018–2021 · strength 0.23
- Jae Ho Byun · 2 shared papers, 2018–2021 · strength 0.23
- Hyoung Jung Kim · 2 shared papers, 2018–2021 · strength 0.23
- Chae Hwa Kwon · 1 shared paper, 2023 · strength 0.18
- Sohee Park · 1 shared paper, 2021 · strength 0.14
- Seong Ho Park · 1 shared paper, 2021 · strength 0.14
- Jong Keon Jang · 1 shared paper, 2021 · strength 0.14
- Sang Hyun Choi · 1 shared paper, 2020 · strength 0.13
- Ki Byung Song · 1 shared paper, 2018 · strength 0.09
- Seung‐Mo Hong · 1 shared paper, 2018 · strength 0.09
- Song Cheol Kim · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.